Friday, May 27, 2011

Emails Show Drug Company Used Third-Party Medical Groups to Influence Regulators, Undercut Rivals

ProPublica, dedicated to investigative journalism in the public interest, continues to shed light on the pharmaceutical industry. This story reveals a public relations campaign unleashed by Sanofi-Aventis through several venerable contacts in the medical world to lobby the FDA to delay approval for a generic drug that threatened their blockbuster patented concoction.

No comments:

Post a Comment